BBB-on-Chip with iPSC-Derived Neurovascular Unit
Source Vatine et al. · Cedars-Sinai Medical Center, Los Angeles, CA, USA / Ben-Gurion University, Israel
Abstract
Vatine et al. developed an iPSC-derived BBB-on-chip achieving physiological TEER values and functional efflux pump activity, enabling CNS drug permeability screening and modeling patient-specific BBB dysfunction in Huntington's disease.
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Vatine et al.. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol